Whether a general practitioner (GP) should order prostate-specific antigen (PSA) testing for a patient is a question that has been unresolved for 25 years. The authors suggest that the image-based diagnostic pathway, rather than the biopsy-driven diagnostic pathway, will answer this question.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
This article describes, in non-technical terms, the methodology of prostate imaging with multiparametric magnetic resonance imaging (mpMRI), and targeted biopsies of lesions within the prostate. The benefits and risks of the new technology are dis-cussed.
Accurate anatomical and functional imaging of the prostate gland, and diagnosis of significant (intermediate- and high-risk) prostate cancer, is now becoming available in Australia. However, there is still a learning curve in the implementation of this technology.
Australian family physician. 2015 Aug [Epub]
Les C Thompson, Morgan R Pokorny
FRACS (Urol), Urologist, Wesley Hospital, Wesley Medical Centre, Brisbane, QLD.